IwataniAyako 2023年6月28日から30日まで米ボストンで開催されます「8th Microbiome Movement Drug Development Summit」に、弊社CEO中原、CSO寺内が登壇いたしますので、お知らせいたします。
CEO中原の登壇予定
CONFERENCE DAY ONE | THURSDAY, JUNE 29
2.30 Clinical Development of Fecal Microbiota Transplantation for Ulcerative Colitis in Japan
• Outlining the multi-site pivotal study of FMT for UC started in 2023 in Japan, led by Juntendo
University
• Sharing the process of a fast-track designation for medical procedures
• Developing a FMT platform in collaboration with Juntendo University to scale the most advanced program of microbiome therapy for UC
Taku Nakahara, Co-founder & Chief Executive Officer, Metagen Therapeutics
CSO寺内の登壇予定
CONFERENCE DAY TWO | FRIDAY, JUNE 30
8.30 International Spotlight: A new initiative for Microbiome Based Drug Discovery Ecosystem Creation in Japan as one of Government Funded Programs
• Outlining the program which is aimed to create a microbiome-based drug discovery ecosystem in Japan
• Navigating the regulatory and CMC/manufacturing activities to overcome the bottleneck of the MBDD, especially for
LBPs
• Detailing this public / private partnership program,funded by the Japan Agency for Medical Research and
Development inviting more than 30 organizations
9.30 Panel Discussion: Global Regulatory Perspectives: US, Asia & Europe Perspectives
• Ensuring vigilance for side effects for FMT and LBPs
• Exploring pathways towards approval nutritional vs live biotherapeutics, what does the future hold?
• Navigating nuances in the regulatory process for therapeutics that aren’t systemically absorbed
Jun Terauchi
Chairperson of Steering Committee Japan Microbiome Consortium
詳細は、以下のウェブサイトにてご覧いただけます。
■8th Microbiome Movement Drug Development Summit
microbiome-summit.com